(+)-catechin multiple interactions ISO RGD:1349315 6480464 Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of B4GALT1 mRNA] CTD PMID:21882252 (-)-demecolcine increases expression ISO RGD:1349315 6480464 Demecolcine results in increased expression of B4GALT1 mRNA CTD PMID:23649840 1,2-dimethylhydrazine multiple interactions ISO RGD:10640 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of B4GALT1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:10640 6480464 1, 2-Dimethylhydrazine results in decreased expression of B4GALT1 mRNA CTD PMID:22206623 1-benzylpiperazine increases expression EXP 6480464 N-benzylpiperazine results in increased expression of B4GALT1 mRNA CTD PMID:26821219 17alpha-ethynylestradiol increases expression ISO RGD:10640 6480464 Ethinyl Estradiol results in increased expression of B4GALT1 mRNA CTD PMID:17555576 , PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:1349315 6480464 Ethinyl Estradiol results in increased expression of B4GALT1 mRNA CTD PMID:14605097 17beta-estradiol increases expression ISO RGD:1349315 6480464 Estradiol results in increased expression of B4GALT1 mRNA CTD PMID:14605097 , PMID:31614463 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1349315 6480464 Dihydrotestosterone results in increased expression of B4GALT1 mRNA CTD PMID:29581250 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:10640 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1349315 6480464 Tetrachlorodibenzodioxin results in increased expression of B4GALT1 mRNA CTD PMID:19684285 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10640 6480464 Tetrachlorodibenzodioxin affects the expression of B4GALT1 mRNA CTD PMID:21570461 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of B4GALT1 mRNA CTD PMID:19643169 4,4'-sulfonyldiphenol increases expression ISO RGD:10640 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of B4GALT1 mRNA CTD PMID:30951980 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions ISO RGD:1349315 6480464 [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of B4GALT1 mRNA, Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of B4GALT1 mRNA] CTD PMID:21882252 4-nonylphenol increases expression ISO RGD:1349315 6480464 4-nonylphenol results in increased expression of B4GALT1 mRNA CTD PMID:14605097 4-octylphenol increases expression ISO RGD:1349315 6480464 4-octylphenol results in increased expression of B4GALT1 mRNA CTD PMID:14605097 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of B4GALT1 mRNA CTD PMID:31881176 acetylsalicylic acid increases expression ISO RGD:1349315 6480464 Aspirin results in increased expression of B4GALT1 mRNA CTD PMID:15456535 Aflatoxin B2 alpha decreases methylation ISO RGD:1349315 6480464 aflatoxin B2 results in decreased methylation of B4GALT1 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:1349315 6480464 Tretinoin results in increased expression of B4GALT1 mRNA CTD PMID:21934132 all-trans-retinoic acid multiple interactions ISO RGD:10640 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of B4GALT1 mRNA CTD PMID:30951980 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of B4GALT1 mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:1349315 6480464 Antirheumatic Agents results in decreased expression of B4GALT1 mRNA CTD PMID:24449571 benzo[a]pyrene decreases expression ISO RGD:10640 6480464 Benzo(a)pyrene results in decreased expression of B4GALT1 mRNA CTD PMID:17942131 benzo[a]pyrene multiple interactions ISO RGD:10640 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of B4GALT1 mRNA CTD PMID:27858113 benzo[a]pyrene multiple interactions ISO RGD:1349315 6480464 [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of B4GALT1 mRNA, Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of B4GALT1 mRNA] CTD PMID:21882252 benzo[a]pyrene increases expression ISO RGD:10640 6480464 Benzo(a)pyrene results in increased expression of B4GALT1 mRNA CTD PMID:27195522 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1349315 6480464 7 more ... CTD PMID:19150397 benzo[b]fluoranthene multiple interactions ISO RGD:10640 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of B4GALT1 mRNA CTD PMID:27858113 benzo[e]pyrene affects methylation ISO RGD:1349315 6480464 benzo(e)pyrene affects the methylation of B4GALT1 intron CTD PMID:30157460 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1349315 6480464 Diethylhexyl Phthalate results in increased expression of B4GALT1 mRNA CTD PMID:31163220 bisphenol A decreases expression ISO RGD:1349315 6480464 bisphenol A results in decreased expression of B4GALT1 mRNA CTD PMID:25047013 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of B4GALT1 mRNA CTD PMID:34947998 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of B4GALT1 mRNA CTD PMID:30816183 , PMID:32528016 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of B4GALT1 mRNA CTD PMID:25181051 bisphenol F multiple interactions ISO RGD:10640 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of B4GALT1 mRNA CTD PMID:30951980 calcitriol increases expression ISO RGD:1349315 6480464 Calcitriol results in increased expression of B4GALT1 mRNA CTD PMID:16002434 captan increases expression ISO RGD:10640 6480464 Captan results in increased expression of B4GALT1 mRNA CTD PMID:31558096 carbon nanotube increases expression ISO RGD:10640 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 chrysene multiple interactions ISO RGD:10640 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of B4GALT1 mRNA CTD PMID:27858113 cobalt dichloride increases expression ISO RGD:1349315 6480464 cobaltous chloride results in increased expression of B4GALT1 mRNA CTD PMID:19376846 copper atom decreases expression EXP 6480464 Copper results in decreased expression of B4GALT1 mRNA CTD PMID:30556269 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of B4GALT1 mRNA CTD PMID:30556269 cyclosporin A decreases expression ISO RGD:10640 6480464 Cyclosporine results in decreased expression of B4GALT1 mRNA CTD PMID:17942131 dexamethasone decreases expression ISO RGD:1349315 6480464 Dexamethasone results in decreased expression of B4GALT1 mRNA CTD PMID:25047013 diazinon increases methylation ISO RGD:1349315 6480464 Diazinon results in increased methylation of B4GALT1 gene CTD PMID:22964155 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of B4GALT1 mRNA CTD PMID:21266533 diethylstilbestrol increases expression ISO RGD:1349315 6480464 Diethylstilbestrol results in increased expression of B4GALT1 mRNA CTD PMID:14605097 dopamine increases expression EXP 6480464 Dopamine results in increased expression of B4GALT1 mRNA CTD PMID:21983523 dorsomorphin multiple interactions ISO RGD:1349315 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1349315 6480464 Doxorubicin results in decreased expression of B4GALT1 mRNA CTD PMID:16404146 , PMID:29803840 estriol increases expression ISO RGD:1349315 6480464 Estriol results in increased expression of B4GALT1 mRNA CTD PMID:14605097 fenoldopam increases expression EXP 6480464 Fenoldopam results in increased expression of B4GALT1 mRNA CTD PMID:21983523 finasteride decreases expression EXP 6480464 Finasteride results in decreased expression of B4GALT1 mRNA CTD PMID:24136188 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of B4GALT1 mRNA CTD PMID:23962444 folic acid multiple interactions ISO RGD:10640 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of B4GALT1 mRNA CTD PMID:22206623 folpet increases expression ISO RGD:10640 6480464 folpet results in increased expression of B4GALT1 mRNA CTD PMID:31558096 genistein increases expression ISO RGD:1349315 6480464 Genistein results in increased expression of B4GALT1 mRNA CTD PMID:14605097 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of B4GALT1 mRNA CTD PMID:22061828 glafenine increases expression EXP 6480464 Glafenine results in increased expression of B4GALT1 mRNA CTD PMID:24136188 ivermectin decreases expression ISO RGD:1349315 6480464 Ivermectin results in decreased expression of B4GALT1 protein CTD PMID:32959892 keratan sulfate increases chemical synthesis ISO RGD:1349315 6480464 B4GALT1 protein results in increased chemical synthesis of Keratan Sulfate CTD PMID:12218059 lipopolysaccharide increases expression ISO RGD:10640 6480464 Lipopolysaccharides results in increased expression of B4GALT1 mRNA CTD PMID:19540263 lithium chloride increases expression ISO RGD:1349315 6480464 Lithium Chloride results in increased expression of B4GALT1 mRNA CTD PMID:23527032 malathion decreases expression ISO RGD:1349315 6480464 Malathion results in decreased expression of B4GALT1 mRNA CTD PMID:32069766 methapyrilene affects methylation ISO RGD:1349315 6480464 Methapyrilene affects the methylation of B4GALT1 intron CTD PMID:30157460 methotrexate affects expression ISO RGD:10640 6480464 Methotrexate affects the expression of B4GALT1 mRNA CTD PMID:18502557 methylseleninic acid affects expression ISO RGD:1349315 6480464 methylselenic acid affects the expression of B4GALT1 mRNA CTD PMID:14617803 paracetamol affects expression ISO RGD:10640 6480464 Acetaminophen affects the expression of B4GALT1 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:1349315 6480464 Acetaminophen results in decreased expression of B4GALT1 mRNA CTD PMID:21420995 , PMID:22230336 paracetamol decreases expression ISO RGD:10640 6480464 Acetaminophen results in decreased expression of B4GALT1 mRNA CTD PMID:17942131 paricalcitol multiple interactions ISO RGD:1349315 6480464 [Phosphorus co-treated with paricalcitol] results in increased expression of B4GALT1 mRNA CTD PMID:17715259 phenylmercury acetate increases expression ISO RGD:1349315 6480464 Phenylmercuric Acetate results in increased expression of B4GALT1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1349315 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of B4GALT1 mRNA CTD PMID:27188386 phosphorus atom multiple interactions ISO RGD:1349315 6480464 [Phosphorus co-treated with paricalcitol] results in increased expression of B4GALT1 mRNA CTD PMID:17715259 phosphorus(.) multiple interactions ISO RGD:1349315 6480464 [Phosphorus co-treated with paricalcitol] results in increased expression of B4GALT1 mRNA CTD PMID:17715259 pirinixic acid decreases expression ISO RGD:10640 6480464 pirinixic acid results in decreased expression of B4GALT1 mRNA CTD PMID:17426115 , PMID:23811191 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:10640 6480464 Pregnenolone Carbonitrile results in increased expression of B4GALT1 mRNA CTD PMID:28903501 SB 431542 multiple interactions ISO RGD:1349315 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1349315 6480464 Silicon Dioxide results in decreased expression of B4GALT1 mRNA CTD PMID:25351596 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of B4GALT1 mRNA CTD PMID:25993096 sodium dichromate increases expression ISO RGD:10640 6480464 sodium bichromate results in increased expression of B4GALT1 mRNA CTD PMID:31558096 Soman increases expression EXP 6480464 Soman results in increased expression of B4GALT1 mRNA CTD PMID:19281266 sulindac decreases expression EXP 6480464 Sulindac results in decreased expression of B4GALT1 mRNA CTD PMID:24136188 sunitinib increases expression ISO RGD:1349315 6480464 Sunitinib results in increased expression of B4GALT1 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:10640 6480464 Tamoxifen affects the expression of B4GALT1 mRNA CTD PMID:17555576 testosterone decreases expression ISO RGD:10640 6480464 Testosterone results in decreased expression of B4GALT1 mRNA CTD PMID:19693291 tetraphene multiple interactions ISO RGD:10640 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of B4GALT1 mRNA CTD PMID:27858113 Tributyltin oxide decreases expression ISO RGD:10640 6480464 bis(tri-n-butyltin)oxide results in decreased expression of B4GALT1 mRNA CTD PMID:17942131 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of B4GALT1 gene CTD PMID:27618143 Triptolide increases expression ISO RGD:10640 6480464 triptolide results in increased expression of B4GALT1 mRNA CTD PMID:32835833 tunicamycin increases expression ISO RGD:1349315 6480464 Tunicamycin results in increased expression of B4GALT1 mRNA CTD PMID:29453283 valproic acid increases expression ISO RGD:1349315 6480464 Valproic Acid results in increased expression of B4GALT1 mRNA CTD PMID:23179753 , PMID:23527032 valproic acid multiple interactions ISO RGD:1349315 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of B4GALT1 mRNA CTD PMID:27188386
